Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-24

Clinical Trial Update: A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing doxycycline to placebo for improving filarial lymphedema in Mali has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: The Task Force for Global Health | Conditions: Lymphedema, Lymphatic Filariasis | Phase 3 | Status: COMPLETED